Dyne Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.69 |
0.86 |
74.49 |
327.71 |
737.00 |
| Przychód Δ r/r |
0.00% |
inf% |
24.65% |
8532.19% |
339.92% |
124.89% |
| Przychód (min) |
0.00 |
0.69 |
0.83 |
71.59 |
327.71 |
737.00 |
| Przychód (max) |
0.00 |
0.69 |
0.89 |
77.40 |
327.71 |
737.00 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-329.61 |
-344.55 |
-363.75 |
-475.88 |
-222.30 |
-51.83 |
| Zysk netto % |
-inf% |
-49768.87% |
-42151.70% |
-638.83% |
-67.83% |
-7.03% |
| EPS (średnia) |
-3.47 |
-3.66 |
-3.52 |
-3.12 |
-2.36 |
-0.55 |
| Liczba analityków (Przychody) |
0 |
7 |
14 |
11 |
4 |
5 |
| Liczba analityków (EPS) |
10 |
11 |
14 |
9 |
4 |
3 |
| symbol |
DYN |
DYN |
DYN |
DYN |
DYN |
DYN |